| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | Entrez:608 MIM:109545 HGNC:HGNC:11913 Ensembl:ENSG00000048462 AllianceGenome:HGNC:11913 | |
| Description | TNF receptor superfamily member 17 | |||||
| GTO ID | GTC2129 |
| Trial ID | NCT03994705 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | DesCAR-Tes-11 |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | Descartes-11 in Multiple Myeloma |
| Year | 2019 |
| Country | United States |
| Company sponsor | Cartesian Therapeutics |
| Other ID(s) | DC11A |
| Cohort 1 | |||||||||
|
|||||||||